+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials



High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials



Archives of Internal Medicine 170(9): 751-758



High-dose proton pump inhibitors (PPIs) (80-mg bolus, followed by 8-mg/h continuous infusion for 72 hours) have been widely studied and used. However, to date no concrete evidence has shown that high-dose PPIs are more effective than non-high-dose PPIs. We performed a literature search for randomized controlled trials that compared the use of high-dose PPIs vs non-high-dose PPIs in patients with bleeding peptic ulcer and determined their effects on rebleeding, surgical intervention, and mortality. Outcomes data were combined in a meta-analysis and were reported as odds ratios (ORs) with 95% confidence intervals (CIs). A total of 1157 patients from 7 high-quality randomized studies were included in this meta-analysis. High-dose PPIs and non-high-dose PPIs did not differ in their effects on the rates of rebleeding (7 studies and 1157 patients; OR, 1.30; 95% CI, 0.88-1.91), surgical intervention (6 studies and 1052 patients; 1.49; 0.66-3.37), or mortality (6 studies and 1052 patients; 0.89; 0.37-2.13). Post hoc subgroup analyses revealed that summary outcomes measures were unaffected by severity of signs of recent hemorrhage at initial endoscopy, route of PPI administration, or PPI dose. Compared with non-high-dose PPIs, high-dose PPIs do not further reduce the rates of rebleeding, surgical intervention, or mortality after endoscopic treatment in patients with bleeding peptic ulcer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053544727

Download citation: RISBibTeXText

PMID: 20458081

DOI: 10.1001/archinternmed.2010.100


Related references

Su1798 What is the Optimal Dose for Proton Pump Inhibitor (Ppi) Treatment in Peptic Ulcer (Pu) Bleeding? a Cochrane Systematic Review and Meta-Analysis of Randomized Controlled Trials (Rcts). Gastroenterology 142(5): S-506, 2012

High-dose vs. Low-dose Proton Pump Inhibitors post-endoscopic hemostasis in patients with bleeding peptic ulcer. A meta-analysis and meta-regression analysis. Turkish Journal of Gastroenterology 29(1): 22-31, 2018

High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study. American Journal of Gastroenterology 103(12): 3011-3018, 2008

High- Versus Low-Dose Proton Pump Inhibitors After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding: A Multicentre, Randomized Study. Yearbook of Medicine 2009: 482-483, 2009

Proton pump inhibitors used as high dose intravenous infusion decrease both re-bleeding and mortality in high-risk patients with acute peptic ulcer bleeding A series of meta-analyses. Tulunay, F C , Orme, M European collaboration: Towards drug development and rational drug therapy : 104, 2003

Proton pump inhibitors in the treatment of peptic ulcer bleeding A Cochrane Collaboration meta-analysis of randomized controlled Trials. American Journal of Gastroenterology 98(9 Suppl.): S49-S50, 2003

A real world report on intravenous high-dose and non-high-dose proton-pump inhibitors therapy in patients with endoscopically treated high-risk peptic ulcer bleeding. Gastroenterology Research and Practice 2012: 858612, 2012

Proton pump inhibitors (PPI) in the treatment of peptic ulcer bleeding: a cochrane collaboration meta-analysis of randomized controlled trials (RCTS). American Journal of Gastroenterology 98: S49-S50, 2003

ACP Journal Club: high-dose and non-high-dose proton pump inhibitors after endoscopic treatment do not differ for bleeding peptic ulcers. Annals of Internal Medicine 153(6): Jc3-J11, 2010

Intravenous proton pump inhibitors for peptic ulcer hemorrhage Meta-analysis of randomized controlled trials allowing endoscopic treatment. Gastroenterology 120(5 Suppl. 1): A 248, 2001

High dose intravenous proton pump inhibition decrease both re bleeding and mortality in high risk patients with acute peptic ulcer bleeding a series of meta analyses. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No W1078, 2003

T1942 Proton Pump Inhibitor (Ppi) Treatment for Peptic Ulcer (Pu) Bleeding: An Updated Cochrane Meta-Analysis of Randomized Controlled Trials (Rcts). Gastroenterology 136(5): A-605, 2009

IV proton pump inhibitors with or without endoscopic therapy prevent rebleeding and surgery in patients with peptic ulcer haemorrhage A meta-analysis of randomised controlled trials. Gut 48(Suppl. 1): A8, 2001

Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding. British Journal of Surgery 98(5): 640-644, 2011

Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers. Alimentary Pharmacology and Therapeutics 35(8): 894-903, 2012